Smith & Nephew's 15-minute chart has recently triggered a KDJ Golden Cross and a Bullish Marubozu at 07/22/2025 14:45. This indicates a shift in the momentum of the stock price towards the upside, with potential for further growth. The dominance of buyers in the market suggests that bullish momentum is likely to continue.
Smith & Nephew plc (LSE: SN, NYSE: SNN), a leading medical technology company, has scheduled the release of its second-quarter and first-half 2025 financial results for the period ended June 28, 2025. The company will publish these results on Tuesday, August 5, 2025, at 7:00 a.m. BST (2:00 a.m. EDT), and will also hold a conference call for financial analysts at 8:30 a.m. BST (3:30 a.m. EDT) on the same day [1].
Smith & Nephew operates in approximately 100 countries and generated annual sales of $5.8 billion in 2024. The company's portfolio includes orthopaedics, sports medicine and ENT, and advanced wound management products, and it is a constituent of the FTSE 100 index.
In addition to the financial results, market analysts are closely watching Smith & Nephew's technical indicators. Recent chart analysis suggests a significant shift in the stock's momentum. As of July 22, 2025, at 14:45, the 15-minute chart triggered a KDJ Golden Cross and a Bullish Marubozu, indicating a potential upside in the stock price. These technical indicators suggest that buyers are dominating the market, signaling continued bullish momentum [2].
Investors should stay tuned for the upcoming financial results and the conference call to gain insights into Smith & Nephew's performance and future prospects. The company's strong market presence and diversified product portfolio make it a key player in the medical technology sector.
References:
[1] https://www.investing.com/news/sec-filings/smith--nephew-schedules-release-of-second-quarter-and-halfyear-2025-results-93CH-4144135
[2] [Provided writing topic]
Comments
No comments yet